Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancers|November 27, 2025
Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based RegimensLorenzo Gasperoni, Luca Cancanelli, Andrea Ossato, et al.
Journal of Pharmaceutical Sciences|March 20, 2026
Multidisciplinary exploratory survey: Initial insights into biologic drug handling and regulatory perspectives among healthcare professionalsLéa Sorret, Nathalie Fuentes, Lara Nonis, et al.
Recenti Progressi in Medicina|November 1, 2022
[Application of artificial intelligence for an early comparison of efficacy between new cancer drugs.]Vera Damuzzo, Melania Rivano, Paolo Baldo, et al.
Recenti Progressi in Medicina|April 12, 2017
A survey on patients medication reconciliation process in an oncological hospitalFrida Gorreja, Vera Damuzzo, Umberto Gallo, et al.
Oncotarget|December 25, 2015
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppressionLaura Pinton, Samantha Solito, Vera Damuzzo, et al.
Frontiers in Oncology|May 25, 2026
Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparisonLuna Del Bono, Andrea Ossato, Lorenzo Gasperoni, et al.
Frontiers in Oncology|July 14, 2026
Correction: Efficacy and safety of first-line osimertinib monotherapy versus osimertinib plus platinum-based chemotherapy or amivantamab plus lazertinib in metastatic EGFR-mutated NSCLC: an indirect comparisonLuna Del Bono, Andrea Ossato, Lorenzo Gasperoni, et al.
Journal of the American Society of Nephrology : JASN|February 16, 2013
Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigensCatherine Gottschalk, Vera Damuzzo, Janine Gotot, et al.
Neurology International|December 23, 2021
The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple SclerosisVera Damuzzo, Laura Agnoletto, Roberta Rampazzo, et al.
Drug Safety|January 17, 2019
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal MalignanciesLetizia Procaccio, Vera Damuzzo, Francesca Di Sarra, et al.
Pageof 4